Data as of Mar 10
| +0.14 / +4.27%|
The 2 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 7.50, with a high estimate of 12.00 and a low estimate of 3.00. The median estimate represents a +119.30% increase from the last price of 3.42.
The current consensus among 3 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.